WA
BIOA

Wasatch Advisors’s BioAge Labs BIOA Stock Holding History

Wasatch Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-254,907
Closed -$5.3M – 252
2024
Q3 		$5.3M Buy
+254,907
New +$5.11M 0.03% 194

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors's BIOA Position: Q4 2024 in Review

Wasatch Advisors sold out of BioAge Labs (BIOA) in Q4 2024, closing a stake of 254,907 shares — an estimated $5.3M sold.

Wasatch Advisors first reported a position in BIOA in Q3 2024 and held it in 1 quarter. The position peaked at $5.3M in Q3 2024. 65 funds tracked by Wall St. Rank hold BIOA as of Q4 2024.

  • Wasatch Advisors reported no remaining BioAge Labs position as of Q4 2024 after selling out during the quarter.
  • Wasatch Advisors sold 254,907 BioAge Labs shares in Q4 2024, an estimated $5.3M.
  • Wasatch Advisors first reported a position in BioAge Labs in Q3 2024 and held it in 1 quarter.
  • Wasatch Advisors's BioAge Labs position peaked at $5.3M in Q3 2024.
  • 65 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2024.

Based on Wasatch Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.